Abstract
D r a f t 1
Omega-3 Polyunsaturated Fatty Acids Enriched Hen Eggs Consumption Enhances
sunflower oil in feed mixtures fed to the laying hens was replaced with a mixture of fish
124
(1.33%), linseed (1.33%), rapeseed (1.33%) and soybean (1%) oil. This replacement resulted in 125 changed fatty acids profile in the laying hen's eggs that had reduced n-6 PUFAs and increased n-126 3 PUFAs concentration, and thus a very favorable n-6/n-3 PUFAs ratio (2.63:1).
127
Assessment of fatty acids profile of chicken feed mixtures (n=3) and edible part of eggs
128
(n=10) was performed using gas liquid chromatography. (Cavka et al. 2013; Cavka et al. 2015) .
191

Anthropometric Measurement
192
Body mass index (BMI) was calculated as body mass (kg) divided by height (m) squared.
193
Waist and hip circumference were measured and waist-to-hip ratio (WHR) was calculated. 
Results
220
Content of Fatty Acids in Chicken Feed Mixture and Edible Part of Eggs
221
Fatty acids profiles of chicken feed mixture (g/100 g of total fatty acids) and eggs
222
(mg/100 g edible part) are described in Table 2 . Each OMEGA-3 egg (average weight 58 g) 
Characteristics of Study Population
227
Characteristics of the study population are described in 
Omega-3 PUFAs Enriched Hen Eggs
238
PORH following all three vascular occlusion periods (PORH-1, PORH-2 and PORH-3)
239
was significantly increased in OMEGA-3 group after the study protocol compared to before-diet 
Arterial Blood Pressure Response to Consumption of Omega-3 PUFAs Enriched Hen Eggs
244
BP measurements had demonstrated that all participants were normotensive before the 245 study protocol. There was no difference in BP between two study groups before the study 246 protocol. Table 3 presents BP changes before and after the study protocol in subjects from both 247 study groups. SBP, DBP and MAP were significantly decreased in OMEGA-3 group after the 248 protocol. In Control group, BP was not significantly changed before and after the study protocol. weeks decreased arterial BP in generally normotensive and healthy young population (Table 3) .
316
These results are in concordance with the study by Oh et al., who reported that consumption of 4 317 omega-3 enriched eggs for 4 weeks decreased BP level in healthy individuals (Oh et al. 1991 
Anti-inflammatory Effect of Omega-3 PUFAs
332
The present study has shown a significant decrease of hsCRP compared to baseline in the 333 study group consuming omega-3 PUFAs eggs (ALA+EPA+DHA), while such effect was not 334 observed in subjects consuming standard hen eggs (Table 4) . This is in agreement with studies The strengths of the present study are the following: a) the fact that it is designed as a show effects when consumed in normal daily amounts', future studies based on a populations' 380 habitual weekly omega-3 PUFAs rich food intake should be conducted to confirm the findings.
381
Also, it is important to conduct further investigation of the underlying mechanisms involved in
382
CV health background, and to include not only healthy individuals but also CV patients, which 383 would put the results in the context of reduced risk of developing pathology. Gortan Cappellari, G., Losurdo, P., Mazzucco, S., Panizon, E., Jevnicar, M., Macaluso, L., et n-number of analysis; SD-standard deviation;
∑SFA-saturated fatty acids (C14:0, C15:0, C16:0, C17:0, C18:0, C20:0, C21:0, C23:0); ∑MUFA-monounsaturated fatty acids (C14:1, C16:1, C18:1n9t, C18:1n9c, C20:1n9, C22:1n9); ∑n-6 PUFA-polyunsaturated fatty acids (C18:2n6c, C18:3n6, C20:3n6, C20:4n6, C22:2n6); LA-linoleic acid (C18:2n6c); AA-arachidonic acid (C20:4n6); ∑n-3 PUFA-polyunsaturated fatty acids (C18:3n3, C20:3n3, C20:5n3, C22:6n3); ALA-alpha linolenic acid (C18:3n3); EPA-eicosapentaenoic acid (C20:5n3); DHA-docosahexaenoic acid (C22:6n3); 1 edible part; *P<0.05 Control vs. OMEGA-3 D r a f t Results are presented as mean±SD.
n -number of participants; fBG -fasting blood glucose; hsCRP -high-sensitivity C-reactive protein. 
